---
title: cjc-1295
popular_name: "CJC-1295"
developmental_codes: ["CJC-1295"]
street_names: ["CJC", "CJC-1295"]
product_names: ["CJC-1295 Peptide"]
description: CJC-1295 DAC, also known as DAC:GRF, is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies. It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life.
short_description: "Synthetic GHRH analogue with extended half-life for sustained growth hormone release, improved body composition, and enhanced recovery."
benefits: ["Sustained growth hormone release", "Improved body composition and muscle mass", "Enhanced fat burning and metabolism", "Better sleep quality and recovery", "Improved skin elasticity and hair growth", "Enhanced immune function", "Stimulates growth hormone release"]
dosage_levels: ["Beginner: 1-2mg daily (subcutaneous)", "Intermediate: 2-3mg daily (subcutaneous)", "Advanced: 3-5mg daily (subcutaneous)", "Stack with Ipamorelin for enhanced effects"]
research: ["wikipedia: https://en.wikipedia.org/wiki/cjc-1295", "pubmed: https://pubmed.ncbi.nlm.nih.gov/?term=cjc-1295", "clinical trials: https://clinicaltrials.gov/search?term=cjc-1295", "pubmed study: https://pubmed.ncbi.nlm.nih.gov/38197510/", "pubmed study: https://pubmed.ncbi.nlm.nih.gov/37806509/"]
tags: ["growth hormone", "muscle gain", "fat loss", "subcutaneous"]
affiliate_links: []
is_natty: false
created_at: 2025-10-17T08:25:41.104Z
last_updated_at: 2025-10-18T05:18:17.668Z
---